Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 375 of 1143 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/06
End: 05/31/09
Due: 05/31/10
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 02/11/22
End: 02/17/23
Due: 02/17/24
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 02/01/22
Due: 02/01/23
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 01/15/19
End: 01/31/23
Due: 01/31/24
Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia
Phase: N/A
Priority: Normal
Start: 04/18/17
End: 03/30/19
Due: 03/30/20
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 09/30/08
Due: 09/30/09
Phase: N/A
Priority: Normal
Start: 04/01/23
End: 12/30/25
Due: 12/30/26
Phase: N/A
Priority: Normal
Start: 04/20/20
End: 05/01/20
Due: 05/01/21
Phase: N/A
Priority: Normal
Start: 06/24/22
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 05/22/25
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 08/10/18
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 05/23/25
End: 05/23/25
Due: 05/23/26
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 08/31/20
Due: 08/31/21
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 07/01/21
Due: 07/01/22
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 06/30/18
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 08/09/24
End: 08/31/27
Due: 08/31/28
Phase: N/A
Priority: Normal
Start: 06/01/24
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 12/31/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 01/03/19
End: 09/14/20
Due: 09/14/21